Bone Biologics Correlations

BBLGW Stock  USD 20.20  0.00  0.00%   
The current 90-days correlation between Bone Biologics Corp and Bone Biologics Corp is -0.08 (i.e., Good diversification). The correlation of Bone Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Bone Biologics Correlation With Market

Good diversification

The correlation between Bone Biologics Corp and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Moving against Bone Stock

  0.57GPCR Structure TherapeuticsPairCorr
  0.48CDIOW Cardio DiagnosticsPairCorr
  0.47HOLX HologicPairCorr
  0.47INFU InfuSystems HoldingsPairCorr
  0.45ELVN Enliven TherapeuticsPairCorr
  0.33VINC Vincerx Pharma Earnings Call This WeekPairCorr
  0.31SSKN STRATA Skin Sciences Earnings Call TomorrowPairCorr
  0.62IMMX Immix BiopharmaPairCorr
  0.57MLTX MoonLake ImmunotherapeutiPairCorr
  0.54PMVP Pmv PharmaceuticalsPairCorr
  0.53PYXS Pyxis OncologyPairCorr
  0.49ZURA Zura Bio LimitedPairCorr
  0.43IMRX Immuneering CorpPairCorr
  0.4SCLX Scilex HoldingPairCorr
  0.4ASMB Assembly Biosciences Earnings Call This WeekPairCorr
  0.39AVTE Aerovate TherapeuticsPairCorr
  0.38ATNF 180 Life SciencesPairCorr
  0.36ADVM Adverum BiotechnologiesPairCorr
  0.33REPL Replimune GroupPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
IINNWBBLG
BFRIWBBLG
PETVWBBLG
PETVWBFRIW
PETVWIINNW
KTTAWPETVW
  
High negative correlations   
KTTAWBBLG
KTTAWBFRIW
IINNWBFRIW
KTTAWIINNW
KTTAWPETVW
PETVWIINNW

Risk-Adjusted Indicators

There is a big difference between Bone Stock performing well and Bone Biologics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bone Biologics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Bone Biologics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bone Biologics stock to make a market-neutral strategy. Peer analysis of Bone Biologics could also be used in its relative valuation, which is a method of valuing Bone Biologics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Bone Biologics Corporate Executives

Elected by the shareholders, the Bone Biologics' board of directors comprises two types of representatives: Bone Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bone. The board's role is to monitor Bone Biologics' management team and ensure that shareholders' interests are well served. Bone Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bone Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Shunichi KurodaCoFounder BoardProfile